Results
1 -
10 of
14
(Click
here to explore results)
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 5 Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Ramón Cacabelos, Juan Carlos Carril, Oscar Teijido
, 2017
, Pages 75-141
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 5 Pharmacologic Management of Dopaminergic‐Induced Dyskinesias in Parkinson’s Disease. Mildred D. Gottwald, Michael J. Aminoff
, 2013
, Pages 110-125
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 6 D3 Receptor Agonists and Antagonists as Anti‐Parkinsonian Therapeutic Agents. Mark Johnson, Aloke Dutta
, 2013
, Pages 126-148
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 3 Dopaminergic Treatments for Parkinson’s Disease: Light and Shadows. Nicola Simola
, 2013
, Pages 61-82
- Emerging Drugs and Targets for Parkinson's Disease, Subject Index
, 2013
, Pages 390-402
- 3D Printing in Chemical Sciences: Applications Across Chemistry, CHAPTER 5 3D Printing in Pharmaceutical Chemistry
, 2019
, Pages 138-175
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 13 5‐HT1A Receptors as a Therapeutic Target for Parkinson’s Disease. Saki Shimizu, Yukihiro Ohno
, 2013
, Pages 308-326
- Oxidative Stress and Redox Signalling in Parkinson’s Disease, CHAPTER 11 At the Intersection Between Mitochondrial Dysfunction and Lysosomal Autophagy: Role of PD-Related Neurotoxins and Gene Products. Josephat M. Asiago, Trevor B. Doyle, Vartika Mishra, Aurélie de Rus Jacquet, Jean-Christophe Rochet
, 2017
, Pages 325-388
- Mechanisms and Metal Involvement in Neurodegenerative Diseases, Subject Index
, 2013
, Pages 214-226
- Drug Discovery for Schizophrenia, CHAPTER 9 Protein Interactions with Dopamine Receptors as Potential New Drug Targets for Treating Schizophrenia. Ping Su, Albert H. C. Wong, Fang Liu
, 2015
, Pages 202-233